{
  "meta": {
    "title": "Atrial_Fibrillation_And_Ventricular_Tachycardia",
    "url": "https://brainandscalpel.vercel.app/atrial-fibrillation-and-ventricular-tachycardia-387c4c74.html",
    "scrapedAt": "2025-11-30T08:48:58.859Z"
  },
  "questions": [
    {
      "id": 1,
      "choices": [
        {
          "id": 1,
          "text": "<p><span style=\"font-size:12.0pt;\">Atrial flutter</span></p>"
        },
        {
          "id": 2,
          "text": "<p><span style=\"font-size:12.0pt;\">Atrial fibrillation with pre-excitation</span></p>"
        },
        {
          "id": 3,
          "text": "<p><span style=\"font-size:12.0pt;\">Atrioventricular nodal reentrant tachycardia</span></p>"
        },
        {
          "id": 4,
          "text": "<p><span style=\"font-size:12.0pt;\">Monomorphic ventricular tachycardia</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">You are on call in the emergency department when suddenly you hear the code bell. You rush to the room to find a new arrival, Ms. M. She is a 19-year-old who was out for a jog with a friend when she suddenly and inexplicably passed out. On your arrival, she is unresponsive and pulseless. A 12-lead electrocardiogram is shown in Figure IV-48. Which of the following rhythms is the cause of her cardiac arrest?<br><img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3d535v34tlady.cloudfront.net/V3/NEETPGMCQ/202501079756a13d-0055-4844-8480-affb1450b734.jpg\"></span></p>",
      "unique_key": "DT1295037",
      "question_audio": null,
      "question_video": null,
      "map_id": 1295037,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p>1. Understanding Pre-excited Atrial Fibrillation (AF):</p>\r\n<ul>\r\n<li><strong>Definition:</strong> Pre-excited AF occurs when atrial fibrillation is conducted through an <strong>accessory pathway (AP),</strong> bypassing the normal <strong>atrioventricular (AV) nodal delay.</strong></li>\r\n<li><strong>Mechanism:</strong>\r\n<ul>\r\n<li>The AP provides a <strong>direct route for atrial impulses to reach the ventricles,</strong> often faster than conduction through the AV node.</li>\r\n<li>In AF, this leads to <strong>rapid, irregular ventricular activation</strong> because both the AV node and the AP conduct impulses to the ventricles.</li>\r\n</ul>\r\n</li>\r\n<li><strong>Risk:</strong> Pre-excited AF can result in <strong>ventricular fibrillation (VF)</strong> if the accessory pathway allows rapid, repetitive conduction, leading to <strong>sudden cardiac arrest.</strong></li>\r\n</ul>\r\n<p>2. ECG Findings in Pre-excited AF:</p>\r\n<ul>\r\n<li><strong>Irregular, wide-complex QRS:</strong> The ECG typically shows a wide QRS complex with an irregular rhythm due to the <strong>irregular atrial activity</strong> in AF.</li>\r\n<li><strong>QRS Morphology:</strong> The QRS complexes often look bizarre and vary from beat to beat, reflecting fusion between conduction through the AV node and the AP.</li>\r\n<li><strong>No discernible P waves:</strong> Atrial activity is chaotic due to fibrillation, and <strong>P waves are absent.</strong></li>\r\n</ul>\r\n<p>3. Differentiating from Other Options:</p>\r\n<ul>\r\n<li><strong>A. Atrial Flutter:</strong>\r\n<ul>\r\n<li>Atrial flutter is usually a <strong>regular rhythm</strong> with characteristic <strong>\"sawtooth\" flutter waves</strong> in the atria.</li>\r\n<li>It does not present with an <strong>irregular, wide-complex QRS</strong> pattern as seen in this case.</li>\r\n</ul>\r\n</li>\r\n<li><strong>C. Atrioventricular Nodal Reentrant Tachycardia (AVNRT):</strong>\r\n<ul>\r\n<li>AVNRT is a <strong>narrow-complex tachycardia</strong> due to a reentry circuit within or around the AV node.</li>\r\n<li>It would not cause a <strong>wide, irregular QRS</strong> pattern or be life-threatening in the same way.</li>\r\n</ul>\r\n</li>\r\n<li><strong>D. Monomorphic Ventricular Tachycardia:</strong>\r\n<ul>\r\n<li>Monomorphic VT is a <strong>regular wide-complex tachycardia</strong> with a single QRS morphology throughout.</li>\r\n<li>The irregularity in this case and absence of monomorphic QRS complexes make VT unlikely.</li>\r\n</ul>\r\n</li>\r\n<li><strong>Possible DD. Torsades de Pointes:</strong>\r\n<ul>\r\n<li>Torsades is a polymorphic VT associated with a <strong>prolonged QT interval.</strong></li>\r\n<li>It has a distinctive \"twisting\" QRS morphology, which is not typical in this patient's presentation.</li>\r\n</ul>\r\n</li>\r\n</ul>\r\n<p><strong>Key Takeaways:</strong></p>\r\n<ul>\r\n<li><strong>Pre-excited AF</strong> is a potentially life-threatening arrhythmia due to rapid conduction through an accessory pathway, leading to <strong>ventricular fibrillation risk.</strong></li>\r\n<li><strong>ECG</strong> in pre-excited AF shows <strong>wide-complex, irregular QRS</strong> due to fusion between AV nodal and accessory pathway conduction.</li>\r\n<li><strong>Immediate cardioversion</strong> is needed in unstable patients to prevent progression to cardiac arrest.</li>\r\n</ul>\r\n",
      "correct_choice_id": 2,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 2,
      "choices": [
        {
          "id": 11,
          "text": "<p><span style=\"font-size:12.0pt;\">Adenosine</span></p>"
        },
        {
          "id": 12,
          "text": "<p><span style=\"font-size:12.0pt;\">Amiodarone</span></p>"
        },
        {
          "id": 13,
          "text": "<p><span style=\"font-size:12.0pt;\">Diltiazem</span></p>"
        },
        {
          "id": 14,
          "text": "<p><span style=\"font-size:12.0pt;\">All of the above</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">In the patient described in question 1, which of the following medications is absolutely contraindicated in this situation?</span></p>",
      "unique_key": "DT1295353",
      "question_audio": null,
      "question_video": null,
      "map_id": 1295353,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p>1. <strong>Understanding Pre-excited Atrial Fibrillation (AF)</strong>:</p>\r\n<ul>\r\n<li><strong>Pre-excited AF</strong> occurs when atrial fibrillation is conducted through an <strong>accessory pathway (AP)</strong> that bypasses the normal AV nodal delay.</li>\r\n<li>The AP allows rapid conduction of atrial impulses to the ventricles, which can <strong>lead to dangerously high ventricular rates</strong>, increasing the risk of ventricular fibrillation (VF) and sudden cardiac death.</li>\r\n<li>The goal in treating pre-excited AF is to either <strong>terminate the arrhythmia</strong> or <strong>control ventricular response</strong> without accelerating conduction through the AP.</li>\r\n</ul>\r\n<h4>2. <strong>Contraindicated Medications</strong>:</h4>\r\n<ul>\r\n<li><strong>AV Nodal Blockers </strong>:Medications like <strong>adenosine, diltiazem, metoprolol, and amiodarone</strong> act by <strong>slowing conduction through the AV node</strong>.</li>\r\n<li>In pre-excited AF, AV nodal blockers <strong>redirect more impulses through the accessory pathway</strong>, exacerbating ventricular response rates and heightening the risk for VF.</li>\r\n</ul>\r\n<img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3d535v34tlady.cloudfront.net/V3/NEETPGMCQ/202501082ea77eb8-d954-4d98-8bea-e8c40cb56a22.png\">\r\n<p>3. <strong>Appropriate Treatment Options</strong>:</p>\r\n<ul>\r\n<li><strong>Electrical Cardioversion</strong>: If the patient is <strong>hemodynamically unstable</strong>, immediate <strong>synchronized cardioversion</strong> is recommended.</li>\r\n<li><strong>Anti-arrhythmic Medications</strong>: For <strong>hemodynamically stable patients</strong>, use <strong>procainamide or ibutilide</strong>, which <strong>slow conduction through both the AV node and accessory pathway</strong> and safely control ventricular response.</li>\r\n</ul>\r\n<p>4. <strong>Key Points</strong>:</p>\r\n<ul>\r\n<li><strong>Avoid AV Nodal Blockers</strong>: Drugs that slow conduction through the AV node increase AP conduction risk.</li>\r\n<li><strong>Electrical Cardioversion or Procainamide</strong>: These are safer and effective choices for managing pre-excited AF.</li>\r\n</ul>\r\n<p>Key Takeaways:</p>\r\n<ul>\r\n<li><strong>Avoid AV nodal blockers</strong> (adenosine, amiodarone, diltiazem, metoprolol) in pre-excited AF, as they can lead to dangerously high ventricular rates.</li>\r\n<li><strong>Electrical cardioversion</strong> or specific antiarrhythmics like <strong>procainamide</strong> are preferred to prevent rapid ventricular response via the accessory pathway.</li>\r\n</ul>\r\n",
      "correct_choice_id": 14,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 3,
      "choices": [
        {
          "id": 21,
          "text": "<p><span style=\"font-size:12.0pt;\">Anticoagulation for thromboembolic prophylaxis is never required.</span></p>"
        },
        {
          "id": 22,
          "text": "<p><span style=\"font-size:12.0pt;\">It is dependent on the cavotricuspid isthmus for conduction.</span></p>"
        },
        {
          "id": 23,
          "text": "<p><span style=\"font-size:12.0pt;\">It usually is associated with a ventricular rate of approximately 80-100 beats/min.</span></p>"
        },
        {
          "id": 24,
          "text": "<p><span style=\"font-size:12.0pt;\">The wave of depolarization propagates clockwise when viewed looking toward the tricuspid valve from the ventricular apex.</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">You are seeing Mr. Joe Murrow, a man from rural Georgia who has atrial flutter. You confirm the presence of atrial flutter on his surface electrocardiogram. Which of the following is true of typical or common atrial flutter?</span></p>",
      "unique_key": "DT1295354",
      "question_audio": null,
      "question_video": null,
      "map_id": 1295354,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<ul>\r\n<li><strong>Atrial flutter</strong> is often due to a reentrant circuit that depends on the cavotricuspid isthmus.</li>\r\n<li><strong>Anti-coagulation</strong> may be required to prevent thromboembolism, especially in patients with risk factors.</li>\r\n<li>The <strong>typical ventricular rate</strong> is usually around 150 beats/min in untreated cases, not 80-100 beats/min.</li>\r\n<li>The reentrant wave typically propagates <strong>counterclockwise</strong> when viewed from the ventricular apex.</li>\r\n<li><strong>Vagal maneuvers</strong> typically reduce the ventricular rate by increasing AV nodal blockade.</li>\r\n</ul>\r\n<p><strong>Key Takeaways:</strong></p>\r\n<ul>\r\n<li>Atrial flutter often involves a reentrant circuit dependent on the cavotricuspid isthmus, which is the target in catheter ablation.</li>\r\n<li>Rate control and anticoagulation are crucial in managing atrial flutter to prevent complications.</li>\r\n</ul>\r\n",
      "correct_choice_id": 22,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 4,
      "choices": [
        {
          "id": 31,
          "text": "<p><span style=\"font-size:12.0pt;\">Catheter ablation has a high success rate in common atrial flutter.</span></p>"
        },
        {
          "id": 32,
          "text": "<p><span style=\"font-size:12.0pt;\">Electrical cardioversion is never warranted.</span></p>"
        },
        {
          "id": 33,
          "text": "<p><span style=\"font-size:12.0pt;\">Rate control is often more easily achieved in atrial flutter than in atrial fibrillation.</span></p>"
        },
        {
          "id": 34,
          "text": "<p><span style=\"font-size:12.0pt;\">The most reasonable therapeutic strategy for the first presentation of atrial flutter is rate control.</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Which of the following statements regarding the treatment of atrial flutter is true?</span></p>",
      "unique_key": "DT1295355",
      "question_audio": null,
      "question_video": null,
      "map_id": 1295355,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<ul>\r\n<li><strong>Catheter ablation</strong> is effective in treating typical atrial flutter, with a high success rate by targeting the cavotricuspid isthmus.</li>\r\n<li><strong>Electrical cardioversion</strong> can be used in cases where rapid rate control is required or in hemodynamically unstable patients.</li>\r\n<li><strong>Rate control</strong> is often more challenging in atrial flutter than atrial fibrillation due to its predictable rapid atrial rate.</li>\r\n<li>The initial treatment strategy often involves <strong>rate control</strong> and anticoagulation if risk factors are present.</li>\r\n<li>Atrial flutter still carries a risk of <strong>thromboembolic events</strong>, and anticoagulation may be required based on individual risk factors.</li>\r\n</ul>\r\n<p><strong>Key Takeaways:</strong></p>\r\n<ul>\r\n<li>Catheter ablation is the preferred definitive treatment for common atrial flutter with high success.</li>\r\n<li>Rate control and anticoagulation strategies are similar to atrial fibrillation in atrial flutter.</li>\r\n</ul>\r\n",
      "correct_choice_id": 31,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 5,
      "choices": [
        {
          "id": 41,
          "text": "<p><span style=\"font-size:12.0pt;\">Incidence decreases with age.</span></p>"
        },
        {
          "id": 42,
          "text": "<p><span style=\"font-size:12.0pt;\">More common in men than in women.</span></p>"
        },
        {
          "id": 43,
          "text": "<p><span style=\"font-size:12.0pt;\">It is not associated with an increased risk of mortality.</span></p>"
        },
        {
          "id": 44,
          "text": "<p><span style=\"font-size:12.0pt;\">It is not more common in people with a past medical history of hypertension.</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">You are evaluating Mr. Grady Stein, who has atrial fibrillation confirmed on an electrocardiogram. Which of the following is true regarding the epidemiology of atrial fibrillation?</span></p>",
      "unique_key": "DT1295356",
      "question_audio": null,
      "question_video": null,
      "map_id": 1295356,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Epidemiology of Atrial Fibrillation (AF)</strong>:</p>\r\n<ul>\r\n<li><strong>Gender Prevalence</strong>: AF is <strong>more common in men</strong> than in women.</li>\r\n<li><strong>Age Factor</strong>: The <strong>incidence and prevalence of AF increase with age</strong>, especially among individuals over 60.</li>\r\n<li><strong>Risk Factors</strong>: Key risk factors include <strong>hypertension, heart disease, diabetes, and obesity</strong>.</li>\r\n<li><strong>Mortality Risk</strong>: AF is associated with an increased risk of <strong>mortality</strong>, often due to complications like stroke, heart failure, and thromboembolic events.</li>\r\n</ul>\r\n<p><strong>Review of Each Option</strong>:</p>\r\n<ul>\r\n<li><strong>A. Incidence decreases with age</strong>: Incorrect. The incidence of AF actually <strong>increases with age</strong>.</li>\r\n<li><strong>B. More common in men than in women</strong>: Correct. AF is statistically <strong>more prevalent in men</strong>.</li>\r\n<li><strong>C. It is not associated with an increased risk of mortality</strong>: Incorrect. AF is associated with a significant <strong>increase in mortality</strong> risk, particularly due to stroke and cardiovascular complications.</li>\r\n<li><strong>D. It is not more common in people with a past medical history of hypertension</strong>: Incorrect. Hypertension is a <strong>major risk factor</strong> for AF, making it more common in those with a history of high blood pressure.</li>\r\n</ul>\r\n<p><strong>Key Takeaways:</strong></p>\r\n<ul>\r\n<li><strong>AF is more common in men</strong> and <strong>increases with age</strong>.</li>\r\n<li><strong>Hypertension</strong> and other cardiovascular risk factors are strongly linked to AF.</li>\r\n<li><strong>Stroke prevention</strong> and <strong>rate control</strong> are critical to reducing morbidity and mortality in AF management.</li>\r\n</ul>\r\n",
      "correct_choice_id": 42,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 6,
      "choices": [
        {
          "id": 51,
          "text": "<p><span style=\"font-size:12.0pt;\">200-J QRS-synchronous shock</span></p>"
        },
        {
          "id": 52,
          "text": "<p><span style=\"font-size:12.0pt;\">Adenosine 6 mg IV</span></p>"
        },
        {
          "id": 53,
          "text": "<p><span style=\"font-size:12.0pt;\">Digoxin 500 mcg IV</span></p>"
        },
        {
          "id": 54,
          "text": "<p><span style=\"font-size:12.0pt;\">Metoprolol 5 mg IV</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Mr. Alexander Beaux, an 86-year-old man with heart failure, presents with palpitations, weakness, dizziness, and dyspnea. On examination, his heart rate is irregularly irregular at 160 beats/min, and his blood pressure is 50/30. An ECG confirms atrial fibrillation with rapid ventricular response. What is the most reasonable next therapeutic step?</span></p>",
      "unique_key": "DT1295357",
      "question_audio": null,
      "question_video": null,
      "map_id": 1295357,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<ol>\n<li><strong>Hemodynamic Instability in Atrial Fibrillation with Rapid Ventricular Response</strong>:\n<ul>\n<li>Mr. Beaux presents with symptoms of <strong>hemodynamic instability</strong> due to atrial fibrillation (AF) with a rapid ventricular response. His <strong>blood pressure is critically low (50/30 mmHg)</strong>, and he exhibits <strong>altered mental status</strong> and signs of <strong>poor perfusion</strong> (cool, clammy skin).</li>\n<li>AF with a rapid ventricular rate can severely compromise cardiac output, especially in patients with underlying heart failure or limited cardiac reserve. The high ventricular rate (160 beats per minute) prevents adequate ventricular filling, leading to reduced stroke volume and hypotension.</li>\n</ul>\n</li>\n<li><strong>Indication for Urgent Electrical Cardioversion</strong>:\n<ul>\n<li>For patients with AF who exhibit <strong>severe hypotension, altered mental status, acute heart failure, or signs of shock</strong>, <strong>immediate electrical cardioversion</strong> is indicated to restore sinus rhythm.</li>\n<li><strong>QRS-synchronous cardioversion</strong> ensures the shock is delivered at an appropriate point in the cardiac cycle, minimizing the risk of inducing ventricular fibrillation. Starting with <strong>200 J</strong> of energy is a standard initial approach in adults.</li>\n</ul>\n</li>\n<li><strong>Effect of Cardioversion</strong>:\n<ul>\n<li>Electrical cardioversion restores sinus rhythm, improving cardiac output by reestablishing atrial contraction, which contributes to ventricular filling, and slowing the ventricular rate.</li>\n<li>In hemodynamically unstable patients, <strong>cardioversion is prioritized</strong> over pharmacologic rate control, as it provides immediate correction of rhythm and can rapidly improve perfusion and stabilize blood pressure.</li>\n</ul>\n</li>\n</ol>\n<p><strong>Option B: Adenosine 6 mg IV</strong>:</p>\n<ul>\n<li><strong>Adenosine</strong> acts primarily by transiently blocking AV nodal conduction, which can terminate <strong>supraventricular tachycardias (SVT)</strong> but is <strong>ineffective for atrial fibrillation</strong>.</li>\n<li>In AF, adenosine may cause temporary AV block but will not restore sinus rhythm or slow down the atrial rate. Given Mr. Beaux&rsquo;s unstable status, adenosine would not provide any therapeutic benefit and may delay necessary intervention.</li>\n</ul>\n<p><strong>Option C: Digoxin 500 mcg IV</strong>:</p>\n<ul>\n<li><strong>Digoxin</strong> can be used for rate control in AF, particularly in patients with heart failure, as it increases vagal tone, slowing AV nodal conduction. However, digoxin <strong>has a delayed onset of action</strong> and is not effective for rapid, acute rate control in an emergency setting.</li>\n<li>In a hemodynamically unstable patient, digoxin would not provide the immediate control necessary to stabilize the patient&rsquo;s condition. Therefore, it is unsuitable in this acute scenario where rapid cardioversion is needed.</li>\n</ul>\n<p><strong>Option D: Metoprolol 5 mg IV</strong>:</p>\n<ul>\n<li><strong>Metoprolol</strong> is a beta-blocker that reduces heart rate by slowing AV nodal conduction and can be effective for rate control in AF under stable conditions.</li>\n<li>However, in Mr. Beaux&rsquo;s case, metoprolol is <strong>contraindicated</strong> due to his <strong>severe hypotension</strong> and evidence of poor perfusion. Administering a beta-blocker could exacerbate hypotension and further compromise cardiac output, worsening his instability.</li>\n</ul>\n<p><strong>Option E: Transcutaneous Pacing at 80 beats/min</strong>:</p>\n<ul>\n<li><strong>Transcutaneous pacing</strong> is used in cases of severe bradycardia or heart block to maintain an adequate heart rate. In AF with rapid ventricular response, pacing would not correct the tachyarrhythmia or reduce the high ventricular rate.</li>\n<li>Transcutaneous pacing would not address the underlying issue of AF and could worsen the clinical situation by creating competition between the intrinsic and paced rhythms.</li>\n</ul>\n<p><strong>Key Takeaways:</strong></p>\n<ul>\n<li><strong>Immediate synchronized electrical cardioversion</strong> is the preferred treatment for patients with <strong>AF and hemodynamic instability</strong> due to its rapid effect on restoring sinus rhythm.</li>\n<li>Other medications, including <strong>adenosine, digoxin, and beta-blockers</strong>, are not suitable in unstable patients as they either do not address AF or could worsen hypotension.</li>\n<li><strong>Cardioversion</strong> in AF with rapid ventricular response is critical in cases where cardiac output is severely compromised, such as in this patient with heart failure and signs of shock.</li>\n</ul>",
      "correct_choice_id": 51,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 7,
      "choices": [
        {
          "id": 61,
          "text": "<p><span style=\"font-size:12.0pt;\">Arrange for immediate cardioversion to sinus rhythm</span></p>"
        },
        {
          "id": 62,
          "text": "<p><span style=\"font-size:12.0pt;\">Initiate amiodarone orally and arrange electrical cardioversion after one week</span></p>"
        },
        {
          "id": 63,
          "text": "<p><span style=\"font-size:12.0pt;\">Initiate aspirin 325 mg daily</span></p>"
        },
        {
          "id": 64,
          "text": "<p><span style=\"font-size:12.0pt;\">Initiate warfarin</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">You are treating Ms. Sarma, a 22-year-old woman with rheumatic mitral stenosis and newly identified atrial fibrillation. Her CHA2DS2-VASc score is 1 (for female \"Sex Category\"). Which of the following represents the appropriate approach to stroke prevention?</span></p>",
      "unique_key": "DT1295358",
      "question_audio": null,
      "question_video": null,
      "map_id": 1295358,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p>1. <strong>Anticoagulation in Mitral Stenosis with Atrial Fibrillation</strong>:</p>\r\n<ul>\r\n<li><strong>High Thromboembolic Risk</strong>: Patients with <strong>rheumatic mitral stenosis</strong> and AF are at an elevated risk of <strong>thromboembolism</strong>, particularly <strong>stroke</strong>.</li>\r\n<li><strong>Warfarin as Preferred Therapy</strong>: In this scenario, <strong>warfarin</strong> is the recommended anticoagulant, as <strong>direct oral anticoagulants (DOACs)</strong>, such as apixaban, have <strong>not been adequately studied or recommended</strong> for patients with rheumatic mitral stenosis. Warfarin effectively prevents stroke in this high-risk group.</li>\r\n<li><strong>CHA2DS2-VASc Score Irrelevant</strong>: Unlike non-valvular AF, <strong>all patients with mitral stenosis and AF are considered high-risk</strong>, warranting anticoagulation regardless of their CHA2DS2-VASc score.</li>\r\n</ul>\r\n<p>2. <strong>Explanation of Each Option</strong>:</p>\r\n<ul>\r\n<li><strong>Apixaban</strong>: Not recommended in <strong>rheumatic mitral stenosis</strong> due to insufficient evidence in this specific condition.</li>\r\n<li><strong>Aspirin</strong>: Inadequate for stroke prevention in patients with AF and mitral stenosis, as it does not provide sufficient anticoagulation.</li>\r\n<li><strong>Cardioversion</strong>: While an option for rhythm control, <strong>cardioversion requires anticoagulation first</strong> to minimize the risk of embolic events. Immediate cardioversion is not prioritized here without anticoagulation.</li>\r\n</ul>\r\n<p>3. <strong>Key Takeaways</strong>:</p>\r\n<ul>\r\n<li><strong>Warfarin for Rheumatic Mitral Stenosis with AF</strong>: Warfarin is the first-line anticoagulant for preventing thromboembolic events in patients with AF and mitral stenosis.</li>\r\n<li><strong>DOACs Not Indicated</strong>: DOACs are typically used for non-valvular AF but are <strong>not indicated</strong> for valvular AF involving mitral stenosis.</li>\r\n<li><strong>Immediate Anticoagulation</strong>: Prioritize warfarin initiation over cardioversion or aspirin for stroke prevention in mitral stenosis with AF.</li>\r\n</ul>\r\n<p>Key Takeaways:</p>\r\n<ul>\r\n<li><strong>Mitral stenosis with AF</strong> necessitates <strong>warfarin</strong> anticoagulation due to a high stroke risk.</li>\r\n<li><strong>DOACs are not recommended</strong> in rheumatic mitral stenosis.</li>\r\n<li><strong>Aspirin alone is insufficient</strong>; cardioversion should only follow anticoagulation.</li>\r\n</ul>\r\n",
      "correct_choice_id": 64,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 8,
      "choices": [
        {
          "id": 71,
          "text": "<p><span style=\"font-size:12.0pt;\">Atrial flutter with variable conduction</span></p>"
        },
        {
          "id": 72,
          "text": "<p><span style=\"font-size:12.0pt;\">Multifocal premature ventricular contractions</span></p>"
        },
        {
          "id": 73,
          "text": "<p><span style=\"font-size:12.0pt;\">Non-sustained ventricular tachycardia</span></p>"
        },
        {
          "id": 74,
          "text": "<p><span style=\"font-size:12.0pt;\">Normal rhythm</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Ms. Handrew presents with occasional palpitations. Her rhythm strip (Figure IV-56) is consistent with which of the following rhythms? <br><img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3d535v34tlady.cloudfront.net/V3/NEETPGMCQ/2025010801bf3c52-fdf2-4fb8-9cfc-f39520080d59.jpg\"></span></p>",
      "unique_key": "DT1295359",
      "question_audio": null,
      "question_video": null,
      "map_id": 1295359,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<ul>\r\n<li>The rhythm strip shows <strong>multifocal premature ventricular contractions (PVCs)</strong>, identifiable by the presence of PVCs with different morphologies, indicating multiple ectopic foci.</li>\r\n<li><strong>Atrial flutter</strong> would present with a characteristic sawtooth pattern.</li>\r\n<li><strong>Non-sustained ventricular tachycardia</strong> would show a brief run of wide-complex tachycardia lasting less than 30 seconds.</li>\r\n<li><strong>Sustained ventricular tachycardia</strong> lasts more than 30 seconds or requires termination.</li>\r\n</ul>\r\n<p><strong>Key Takeaways:</strong></p>\r\n<ul>\r\n<li>Multifocal PVCs indicate ectopic activity from multiple ventricular foci, often seen in patients with underlying cardiac disease.</li>\r\n<li>Differentiating PVCs from sustained arrhythmias like VT is important for appropriate management.</li>\r\n</ul>\r\n",
      "correct_choice_id": 72,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 9,
      "choices": [
        {
          "id": 81,
          "text": "<p><span style=\"font-size:12.0pt;\">Administer 100% oxygen by nonrebreather face mask</span></p>"
        },
        {
          "id": 82,
          "text": "<p><span style=\"font-size:12.0pt;\">Administer 5 mg IV metoprolol</span></p>"
        },
        {
          "id": 83,
          "text": "<p><span style=\"font-size:12.0pt;\">Administer procainamide IV</span></p>"
        },
        {
          "id": 84,
          "text": "<p><span style=\"font-size:12.0pt;\">Unsynchronized defibrillation with 200 J</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">You are called to the room of an unresponsive 78-year-old patient. The rhythm strip (Figure) shows ventricular tachycardia (VT) with an odd, alternating QRS morphology, and the patient is pulseless. What is the most correct first action? <br><img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3d535v34tlady.cloudfront.net/V3/NEETPGMCQ/202501081687de16-bef5-4aab-a9eb-0128b504a231.jpg\"></span></p>",
      "unique_key": "DT1295360",
      "question_audio": null,
      "question_video": null,
      "map_id": 1295360,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p>Rationale for Choosing Unsynchronized Defibrillation:</p>\n<ol>\n<li><strong>Pulseless Ventricular Tachycardia Management</strong>:\n<ul>\n<li>The patient is unresponsive and pulseless, indicating a state of <strong>cardiac arrest due to pulseless VT</strong>. In such cases, the primary objective is to promptly restore a viable cardiac rhythm to prevent irreversible organ damage.</li>\n<li><strong>Defibrillation</strong> is the treatment of choice in pulseless VT or ventricular fibrillation (VF) because it delivers an electrical shock intended to depolarize all myocardial cells simultaneously, interrupting the arrhythmia and allowing the normal pacemaker (usually the SA node) to restore rhythm.</li>\n</ul>\n</li>\n<li><strong>Unsynchronized Shock Protocol</strong>:\n<ul>\n<li>In cases of <strong>pulseless VT or VF</strong>, an <strong>unsynchronized shock (defibrillation)</strong> is delivered because these arrhythmias are not organized rhythms and do not respond to synchronized cardioversion.</li>\n<li>The <strong>recommended initial energy level</strong> for defibrillation is <strong>200 J</strong> in adults, which may vary based on specific defibrillator settings or guidelines.</li>\n</ul>\n</li>\n</ol>\n<h4><strong>Incorrect Options:</strong></h4>\n<ol>\n<li><strong>Option A: Administer 100% oxygen by nonrebreather face mask</strong>:\n<ul>\n<li>Although oxygen delivery is important in resuscitation, it is not the primary intervention for pulseless VT. Immediate defibrillation is required to attempt to restore an organized rhythm.</li>\n</ul>\n</li>\n<li><strong>Option B: Administer 5 mg IV metoprolol</strong>:\n<ul>\n<li><strong>Metoprolol</strong>, a beta-blocker, is contraindicated in cases of pulseless VT. Beta-blockers slow the heart rate and can exacerbate hypotension in an unstable patient, but they are not effective in terminating pulseless VT.</li>\n</ul>\n</li>\n<li><strong>Option C: Administer procainamide IV</strong>:\n<ul>\n<li>Procainamide is used for managing hemodynamically stable, monomorphic VT, but it is not indicated in pulseless VT. In cases of cardiac arrest, antiarrhythmic drugs like amiodarone are only considered after initial defibrillation attempts.</li>\n</ul>\n</li>\n</ol>\n<p><strong>Key Takeaways:</strong></p>\n<ul>\n<li><strong>Unsynchronized defibrillation</strong> is the first-line treatment for pulseless VT or VF and must be performed immediately to maximize the chances of restoring a viable cardiac rhythm.</li>\n<li>Administering <strong>beta-blockers, procainamide, or calcium</strong> is not appropriate in this acute, life-threatening scenario.</li>\n</ul>",
      "correct_choice_id": 84,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 10,
      "choices": [
        {
          "id": 91,
          "text": "<p><span style=\"font-size:12.0pt;\">&beta;-Adrenergic receptors</span></p>"
        },
        {
          "id": 92,
          "text": "<p><span style=\"font-size:12.0pt;\">Desmosomal proteins</span></p>"
        },
        {
          "id": 93,
          "text": "<p><span style=\"font-size:12.0pt;\">Potassium channels</span></p>"
        },
        {
          "id": 94,
          "text": "<p><span style=\"font-size:12.0pt;\">Sarcomere proteins</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Ms. Carvella is a 35-year-old woman with no past medical history until 1 month ago when she was admitted to the hospital after experiencing syncope. In the emergency department, she had a cardiac arrest due to monomorphic ventricular tachycardia (VT) with a left bundle branch block morphology. She was resuscitated, and coronary angiography showed normal coronary arteries, with an echocardiogram revealing normal left ventricular function. During her follow-up visit today, leads V1-V3 on her ECG (Figure) display abnormal findings. A mutation in which of the following proteins is most likely responsible for her presentation?<br><img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3d535v34tlady.cloudfront.net/V3/NEETPGMCQ/2025010856b3a208-a723-41c6-be77-f532401568bc.jpg\"></span></p>",
      "unique_key": "DT1295361",
      "question_audio": null,
      "question_video": null,
      "map_id": 1295361,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<ol>\n<li><strong>Arrhythmogenic Right Ventricular Cardiomyopathy (ARVC)</strong>:\n<ul>\n<li>Ms. Carvella's clinical presentation, including <strong>monomorphic ventricular tachycardia with left bundle branch block (LBBB) morphology</strong> and <strong>normal coronary arteries and left ventricular function</strong>, is suggestive of <strong>Arrhythmogenic Right Ventricular Cardiomyopathy (ARVC)</strong>.</li>\n<li>ARVC is an inherited cardiomyopathy characterized by <strong>fibro-fatty replacement of right ventricular myocardium</strong> leading to ventricular arrhythmias, often with LBBB morphology.</li>\n</ul>\n</li>\n<li><strong>Desmosomal Protein Mutations in ARVC</strong>:\n<ul>\n<li>ARVC is commonly caused by mutations in <strong>desmosomal proteins</strong> (e.g., plakoglobin, desmoplakin, plakophilin-2, and desmoglein-2), which are essential for maintaining intercellular adhesion in cardiac myocytes.</li>\n<li>Mutations in these proteins weaken the structural integrity of myocytes, making them prone to damage and replacement by fibro-fatty tissue, leading to arrhythmias.</li>\n</ul>\n</li>\n<li><strong>Diagnosis and ECG Findings</strong>:\n<ul>\n<li>The ECG findings in ARVC can include <strong>epsilon waves in the right precordial leads (V1&ndash;V3)</strong> and <strong>T-wave inversions</strong> in these leads, which may be seen in Figure IV-63A.</li>\n<li>This arrhythmia pattern and history are hallmarks of ARVC and can lead to life-threatening ventricular arrhythmias, particularly in young patients.</li>\n</ul>\n</li>\n</ol>\n<p><strong>Option A: &beta;-Adrenergic receptors</strong>:</p>\n<ul>\n<li>Mutations in &beta;-adrenergic receptors are not associated with monomorphic ventricular tachycardia or ARVC.</li>\n<li>Conditions affecting &beta;-adrenergic receptors (such as genetic sensitivity to adrenergic stimuli) do not typically present with structural abnormalities or arrhythmias characteristic of ARVC.</li>\n</ul>\n<p><strong>Option C: Potassium channels</strong>:</p>\n<ul>\n<li>Mutations in potassium channels are commonly implicated in conditions like <strong>Long QT Syndrome</strong> or <strong>Short QT Syndrome</strong>, which manifest with prolonged or shortened QT intervals and predispose to <strong>polymorphic ventricular tachycardia</strong>, not monomorphic VT with LBBB morphology.</li>\n</ul>\n<p><strong>Option D: Sarcomere proteins</strong>:</p>\n<ul>\n<li>Mutations in sarcomere proteins (such as myosin, actin, or troponin) are primarily associated with <strong>hypertrophic cardiomyopathy (HCM)</strong> and lead to left ventricular hypertrophy and dynamic obstruction, not right ventricular structural disease.</li>\n</ul>\n<p><strong>Other possible options: Sodium channel</strong>:</p>\n<ul>\n<li>Mutations in the sodium channel (SCN5A gene) are associated with <strong>Brugada syndrome</strong> and <strong>Type 3 Long QT Syndrome</strong>. These syndromes present with <strong>polymorphic ventricular arrhythmias</strong> or sudden cardiac arrest, usually without structural abnormalities on imaging.</li>\n</ul>\n<p>Key Takeaways:</p>\n<ul>\n<li>ARVC is an inherited condition characterized by right ventricular fibro-fatty replacement, leading to ventricular arrhythmias.</li>\n<li>Desmosomal protein mutations are most commonly responsible for ARVC, leading to progressive myocyte degeneration and arrhythmic risk.</li>\n<li>ECG findings in ARVC often include epsilon waves and T-wave inversions in right precordial leads, consistent with Ms. Carvella's case.</li>\n</ul>",
      "correct_choice_id": 92,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 11,
      "choices": [
        {
          "id": 101,
          "text": "<p><span style=\"font-size:12.0pt;\">Arrhythmogenic right ventricular cardiomyopathy</span></p>"
        },
        {
          "id": 102,
          "text": "<p><span style=\"font-size:12.0pt;\">Hypertrophic cardiomyopathy</span></p>"
        },
        {
          "id": 103,
          "text": "<p><span style=\"font-size:12.0pt;\">Left ventricular outflow tract VT</span></p>"
        },
        {
          "id": 104,
          "text": "<p><span style=\"font-size:12.0pt;\">Right ventricular outflow tract VT</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Mr. Steinberg is a 28-year-old with no past medical history. He reports episodes of palpitations that often occur during moments of stress, such as singing solos with his local quartet. To simulate the situation, you start a continuous 12-lead ECG and ask him to sing. During his solo, he experiences an episode of monomorphic ventricular tachycardia (VT) with a left bundle branch block (LBBB) morphology and large R waves in leads II, III, and aVF. The rhythm spontaneously resolves. Echocardiogram and cardiac MRI reveal no structural abnormalities. Based on this presentation, you suspect the VT is due to which of the following?</span></p>",
      "unique_key": "DT1295362",
      "question_audio": null,
      "question_video": null,
      "map_id": 1295362,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<ol>\n<li><strong>Characteristics of Right Ventricular Outflow Tract VT</strong>:\n<ul>\n<li><strong>RVOT VT</strong> is a common form of idiopathic ventricular tachycardia that arises from the right ventricular outflow tract. It typically presents in <strong>young patients without structural heart disease</strong> and is often triggered by <strong>sympathetic stimulation</strong>, such as physical or emotional stress.</li>\n<li>This type of VT often has a <strong>left bundle branch block (LBBB) morphology</strong> with an <strong>inferior axis</strong> (positive R waves in leads II, III, and aVF), which matches Mr. Steinberg's ECG findings during the episode.</li>\n</ul>\n</li>\n<li><strong>Diagnostic Clues</strong>:\n<ul>\n<li>The fact that his VT is triggered by emotional stress and resolves spontaneously aligns with <strong>RVOT VT</strong>, as it is commonly catecholamine-sensitive and can be provoked in situations of heightened sympathetic tone.</li>\n<li>The <strong>absence of structural abnormalities</strong> on echocardiogram and cardiac MRI further supports the diagnosis of idiopathic VT, which is typically benign and related to autonomic triggers rather than underlying cardiomyopathy.</li>\n</ul>\n</li>\n</ol>\n<p>Incorrect Options:</p>\n<ol>\n<li><strong>Option A: Arrhythmogenic right ventricular cardiomyopathy (ARVC)</strong>:\n<ul>\n<li>ARVC often presents with structural abnormalities on imaging and typically does not resolve spontaneously. It also has ECG findings such as epsilon waves and T-wave inversions in right precordial leads, which were not observed here.</li>\n</ul>\n</li>\n<li><strong>Option B: Hypertrophic cardiomyopathy (HCM)</strong>:\n<ul>\n<li>HCM would be evident on imaging, showing left ventricular hypertrophy(LVH) and potentially dynamic outflow tract obstruction. HCM typically leads to arrhythmias due to structural heart changes rather than stress-triggered, idiopathic VT.</li>\n</ul>\n</li>\n<li><strong>Option C: Left ventricular outflow tract VT</strong>:\n<ul>\n<li>Left ventricular outflow tract (LVOT) VT has a right bundle branch block (RBBB) morphology rather than LBBB, which does not align with Mr. Steinberg's ECG findings.</li>\n</ul>\n</li>\n<li><strong>DD: Scar-mediated reentrant VT</strong>:\n<ul>\n<li>This type of VT generally occurs in patients with prior myocardial infarction or scarring from structural heart disease, none of which is present in this young, healthy patient.</li>\n</ul>\n</li>\n</ol>\n<p>Key Takeaways:</p>\n<ul>\n<li><strong>RVOT VT</strong> is a common form of idiopathic VT, typically presenting with an LBBB morphology and an inferior axis.</li>\n<li>It is often catecholamine-sensitive, triggered by stress or exercise, and usually occurs in young patients without structural heart disease.</li>\n<li>Treatment is usually conservative, with beta-blockers or calcium channel blockers as first-line options. Catheter ablation may be considered if symptomatic or recurrent.</li>\n</ul>",
      "correct_choice_id": 104,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 12,
      "choices": [
        {
          "id": 111,
          "text": "<p><span style=\"font-size:12.0pt;\">Calcium ryanodine receptor</span></p>"
        },
        {
          "id": 112,
          "text": "<p><span style=\"font-size:12.0pt;\">Desmosomal proteins</span></p>"
        },
        {
          "id": 113,
          "text": "<p><span style=\"font-size:12.0pt;\">Potassium channel</span></p>"
        },
        {
          "id": 114,
          "text": "<p><span style=\"font-size:12.0pt;\">Sarcomeric proteins</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">You are called to the cardiac intensive care unit to attend to a young patient in cardiac arrest. Upon arrival, you observe the electrocardiogram showing ventricular tachycardia (VT) with a bidirectional QRS morphology, leading you to suspect catecholaminergic polymorphic ventricular tachycardia (CPVT). Mutations in which of the following proteins are most likely responsible for this deadly arrhythmia?</span></p>",
      "unique_key": "DT1295363",
      "question_audio": null,
      "question_video": null,
      "map_id": 1295363,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<ol>\n<li><strong>Catecholaminergic Polymorphic Ventricular Tachycardia (CPVT)</strong>:\n<ul>\n<li>CPVT is a rare but severe arrhythmia disorder that often affects young patients with structurally normal hearts. It is characterized by <strong>polymorphic or bidirectional VT</strong> that is triggered by physical or emotional stress.</li>\n<li><strong>Bidirectional VT</strong> (alternating QRS axis with each beat) is a hallmark of CPVT and is strongly indicative of this arrhythmia.</li>\n</ul>\n</li>\n<li><strong>Calcium Ryanodine Receptor Mutation</strong>:\n<ul>\n<li>CPVT is most commonly caused by mutations in the <strong>RYR2 gene</strong>, which encodes the <strong>calcium ryanodine receptor</strong> in cardiac myocytes. This receptor regulates calcium release from the sarcoplasmic reticulum.</li>\n<li>Mutations in <strong>RYR2</strong> lead to dysregulated calcium handling, particularly under catecholaminergic stimulation (e.g., during exercise or stress), resulting in calcium overload and subsequent ventricular arrhythmias.</li>\n<li>Another gene associated with CPVT is <strong>CASQ2</strong> (calsequestrin 2), which also plays a role in calcium regulation.</li>\n</ul>\n</li>\n<li><strong>Management</strong>:\n<ul>\n<li>CPVT requires immediate attention due to the risk of sudden cardiac death, and <strong>beta-blockers</strong> are the first-line treatment to reduce catecholamine-induced arrhythmias.</li>\n<li><strong>Implantable cardioverter-defibrillators (ICDs)</strong> may be indicated in high-risk cases, particularly if beta-blockers alone do not control symptoms.</li>\n</ul>\n</li>\n</ol>\n<p><strong>Option B: Desmosomal proteins</strong>:</p>\n<ul>\n<li>Mutations in desmosomal proteins are linked to <strong>Arrhythmogenic Right Ventricular Cardiomyopathy (ARVC)</strong>, which involves fibro-fatty replacement of the right ventricle and can result in monomorphic VT, but not bidirectional VT.</li>\n</ul>\n<p><strong>Option C: Potassium channel</strong>:</p>\n<ul>\n<li>Potassium channel mutations are implicated in <strong>Long QT Syndrome</strong> and <strong>Short QT Syndrome</strong>, which may lead to polymorphic VT, but bidirectional VT is not characteristic of these conditions.</li>\n</ul>\n<p><strong>Option D: Sarcomeric proteins</strong>:</p>\n<ul>\n<li>Sarcomeric protein mutations are primarily associated with <strong>Hypertrophic Cardiomyopathy (HCM)</strong>, a condition that predisposes to sudden cardiac death but typically does not cause bidirectional VT.</li>\n</ul>\n<p><strong>Option E: Sodium channel</strong>:</p>\n<ul>\n<li>Mutations in the sodium channel (SCN5A gene) are linked to <strong>Brugada syndrome</strong> and <strong>Type 3 Long QT Syndrome</strong>, which can cause polymorphic VT or sudden death, but not bidirectional VT specifically.</li>\n</ul>\n<p>Key Takeaways:</p>\n<ul>\n<li><strong>CPVT</strong> is a potentially lethal arrhythmia due to mutations in calcium-handling proteins, most commonly the <strong>calcium ryanodine receptor (RYR2)</strong>.</li>\n<li><strong>Bidirectional VT</strong> is a distinctive feature of CPVT, typically triggered by stress or catecholamine release.</li>\n<li>Treatment includes <strong>beta-blockers</strong> and sometimes <strong>ICDs</strong> to prevent sudden cardiac death.</li>\n</ul>",
      "correct_choice_id": 111,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 13,
      "choices": [
        {
          "id": 121,
          "text": "<p><span style=\"font-size:12.0pt;\">Call emergency medical responders urgently to be transported to the emergency department for assessment.</span></p>"
        },
        {
          "id": 122,
          "text": "<p><span style=\"font-size:12.0pt;\">Come into the clinic tomorrow for labs and an ICD interrogation.</span></p>"
        },
        {
          "id": 123,
          "text": "<p><span style=\"font-size:12.0pt;\">Prepare a remote transmission for ICD interrogation.</span></p>"
        },
        {
          "id": 124,
          "text": "<p><span style=\"font-size:12.0pt;\">Present to the local lab urgently to assess electrolytes.</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Mr. Gupta, a long-time cardiomyopathy patient, calls to report that he has received four shocks from his implantable cardioverter defibrillator (ICD) within a short period. He is on metoprolol, lisinopril, aspirin, and eplerenone, and aside from feeling sore from the shocks, he currently feels fine. What is the most appropriate course of action?</span></p>",
      "unique_key": "DT1295364",
      "question_audio": null,
      "question_video": null,
      "map_id": 1295364,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<ol>\n<li><strong>Recurrent ICD Shocks and the Risk of Electrical Storm</strong>:\n<ul>\n<li>Mr. Kasper has received multiple ICD shocks in a short period, indicating possible <strong>recurrent arrhythmias</strong> or an <strong>electrical storm</strong> (a series of episodes of ventricular arrhythmia occurring in rapid succession). This condition is serious and requires immediate evaluation to stabilize rhythm and prevent further shocks.</li>\n<li>The patient's <strong>history of cardiomyopathy</strong> and his current <strong>symptoms of ICD shocks</strong> suggest that his underlying cardiac condition may be worsening or that a new arrhythmic trigger (e.g., electrolyte disturbance, ischemia) has emerged.</li>\n</ul>\n</li>\n<li><strong>Need for Urgent ICD Interrogation and Assessment</strong>:\n<ul>\n<li><strong>ICD interrogation</strong> is necessary to assess the type and frequency of arrhythmias and to adjust device settings if necessary.</li>\n<li>An <strong>emergency department setting</strong> allows for prompt management, including <strong>electrolyte testing, ECG, and access to antiarrhythmic therapy</strong> if needed, to stabilize his heart rhythm.</li>\n</ul>\n</li>\n<li><strong>Risk of Delay</strong>:\n<ul>\n<li>Delaying evaluation could increase the risk of further shocks, which can be distressing and even harmful due to potential hemodynamic instability from recurrent arrhythmias.</li>\n</ul>\n</li>\n</ol>\n<p><strong>Option B: Come into the clinic tomorrow for labs and an ICD interrogation</strong>:</p>\n<ul>\n<li>Waiting until the next day poses a risk for continued arrhythmias and further shocks. Immediate assessment in the emergency department is safer given the potential severity.</li>\n</ul>\n<p><strong>Option C: Prepare a remote transmission for ICD interrogation</strong>:</p>\n<ul>\n<li>Remote ICD interrogation may provide some insight but does not allow for immediate intervention if serious arrhythmias are detected. In cases with multiple shocks, in-person evaluation is preferred.</li>\n</ul>\n<p><strong>Option D: Present to the local lab urgently to assess electrolytes</strong>:</p>\n<ul>\n<li>While electrolyte assessment is important, it is insufficient as a standalone action. Comprehensive evaluation, including ICD interrogation, is essential and can be best managed in the emergency department.</li>\n</ul>\n<p>Key Takeaways:</p>\n<ul>\n<li>Multiple ICD shocks indicate potential <strong>ventricular arrhythmias</strong> or <strong>electrical storm</strong>, which requires immediate evaluation and stabilization.</li>\n<li><strong>Emergency department assessment</strong> with ICD interrogation and possible antiarrhythmic intervention is critical in preventing further shocks and managing underlying arrhythmia triggers.</li>\n</ul>\n<img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3d535v34tlady.cloudfront.net/V3/NEETPGMCQ/20250108fce3c5ea-cb1a-405a-a50e-b2a096e1d7f5.jpg\">",
      "correct_choice_id": 121,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 14,
      "choices": [
        {
          "id": 131,
          "text": "<p><span style=\"font-size:12.0pt;\">Anemia with high-output state</span></p>"
        },
        {
          "id": 132,
          "text": "<p><span style=\"font-size:12.0pt;\">Chronic systemic hypertension with resultant left ventricular hypertrophy and non-systolic heart failure</span></p>"
        },
        {
          "id": 133,
          "text": "<p><span style=\"font-size:12.0pt;\">Hemochromatosis with subsequent restrictive cardiomyopathy</span></p>"
        },
        {
          "id": 134,
          "text": "<p><span style=\"font-size:12.0pt;\">Thyrotoxicosis with high-output state</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 47-year-old post-menopausal woman presents with a recent onset of severe dyspnea over the past few weeks. She denies chest pain, cough, or fever but reports swelling in her legs. On examination, her blood pressure is 145/78 mmHg, heart rate is 123 beats/min, and she exhibits exophthalmos, bilateral inspiratory crackles in the lower lung fields, neck vein distention, and a third heart sound. She also has bilateral lower extremity edema and a fine hand tremor. Which of the following is the most likely pathophysiologic explanation for her heart failure?</span></p>",
      "unique_key": "DT1295365",
      "question_audio": null,
      "question_video": null,
      "map_id": 1295365,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<ol>\n<li><strong>Classic Signs and Symptoms of Thyrotoxicosis</strong>:\n<ul>\n<li>The patient presents with <strong>signs of hyperthyroidism</strong>, including <strong>exophthalmos</strong> and <strong>fine hand tremor</strong>, which are consistent with <strong>thyrotoxicosis</strong>.</li>\n<li>Additional symptoms of <strong>high-output heart failure</strong> (dyspnea, elevated heart rate, inspiratory crackles, and edema) suggest an increase in cardiac workload due to elevated metabolism, which is typical of a high-output state in hyperthyroidism.</li>\n</ul>\n</li>\n<li><strong>High-Output Heart Failure in Thyrotoxicosis</strong>:\n<ul>\n<li>Thyrotoxicosis leads to <strong>increased metabolic demand</strong> and <strong>decreased systemic vascular resistance</strong>, causing the heart to work harder to meet the body's increased needs, eventually leading to <strong>high-output heart failure</strong>.</li>\n<li>Physical findings such as <strong>tachycardia, a third heart sound (S3)</strong>, and <strong>edema</strong> are compatible with congestive heart failure secondary to hyperthyroidism.</li>\n</ul>\n</li>\n<li><strong>Differentiating from Other Conditions</strong>:\n<ul>\n<li>The absence of typical risk factors or symptoms for <strong>myocardial infarction</strong>, <strong>chronic hypertension</strong>, or <strong>hemochromatosis</strong> also makes these other conditions less likely.</li>\n<li>Her symptoms align more closely with the systemic effects of thyrotoxicosis rather than primary cardiac causes of heart failure.</li>\n</ul>\n</li>\n</ol>\n<p><strong>Option A: Anemia with high-output state</strong>:</p>\n<ul>\n<li>Anemia can lead to high-output heart failure; however, there is no indication of anemia in her presentation. Additionally, signs like exophthalmos and tremor are not associated with anemia.</li>\n</ul>\n<p><strong>Option B: Chronic systemic hypertension with resultant left ventricular hypertrophy and non-systolic heart failure</strong>:</p>\n<ul>\n<li>While hypertension can lead to heart failure, it typically presents as <strong>low-output heart failure</strong> due to left ventricular hypertrophy, which does not align with her signs of hyperthyroidism and high-output state.</li>\n</ul>\n<p><strong>Option C: Hemochromatosis with subsequent restrictive cardiomyopathy</strong>:</p>\n<ul>\n<li>Hemochromatosis can lead to restrictive cardiomyopathy, but it does not explain her hyperthyroid symptoms like exophthalmos and tremor.</li>\n</ul>\n<p><strong>Option D: Myocardial infarction with depressed left ventricular systolic function</strong>:</p>\n<ul>\n<li>A myocardial infarction would lead to low-output heart failure with reduced ejection fraction, not a high-output state. The patient lacks symptoms such as chest pain or infarct history.</li>\n</ul>\n<p>Key Takeaways:</p>\n<ul>\n<li><strong>Thyrotoxicosis</strong> can induce high-output heart failure due to increased metabolic demands and reduced vascular resistance.</li>\n<li>High-output heart failure in hyperthyroidism often presents with <strong>tachycardia, dyspnea, peripheral edema, and other signs of congestive heart failure</strong>.</li>\n</ul>",
      "correct_choice_id": 134,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 15,
      "choices": [
        {
          "id": 141,
          "text": "<p><span style=\"font-size:12.0pt;\">Findings consistent with atrioventricular dissociation.</span></p>"
        },
        {
          "id": 142,
          "text": "<p><span style=\"font-size:12.0pt;\">No R wave in lead aVR.</span></p>"
        },
        {
          "id": 143,
          "text": "<p><span style=\"font-size:12.0pt;\">Presence of a monomorphic R wave in leads V1-V6.</span></p>"
        },
        {
          "id": 144,
          "text": "<p><span style=\"font-size:12.0pt;\">The presence of structural heart disease.</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Mr. Winters is a 67-year-old man with a history of myocardial infarction and left ventricular dysfunction. He arrives at the emergency department with a sudden onset of light-headedness and is found to be tachycardic with a heart rate of 170 beats/min. A 12-lead ECG shows a wide complex, regular tachycardia. Which of the following features would make supraventricular tachycardia (SVT) more likely than ventricular tachycardia (VT) with aberrancy?</span></p>",
      "unique_key": "DT1295366",
      "question_audio": null,
      "question_video": null,
      "map_id": 1295366,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<ol>\n<li><strong>Differentiating SVT with Aberrancy from VT</strong>:\n<ul>\n<li>Differentiating <strong>SVT with aberrancy</strong> from <strong>VT</strong> is challenging, especially in patients with a history of heart disease. <strong>VT is more likely in patients with structural heart disease</strong> or a history of myocardial infarction, as is the case with Mr. Winters.</li>\n<li>However, certain <strong>ECG findings</strong> can help distinguish the two. The <strong>absence of an R wave in lead aVR</strong> suggests SVT with aberrancy rather than VT, as a monophasic R wave or RS complex in aVR is more specific for VT.</li>\n</ul>\n</li>\n<li><strong>Additional ECG Clues for VT</strong>:\n<ul>\n<li>VT is more likely if there is <strong>AV dissociation</strong> (indicating separate atrial and ventricular rhythms), <strong>concordance of R or S waves from V1 to V6</strong>, or the presence of a <strong>monophasic R wave in aVR</strong>.</li>\n<li>In this scenario, the <strong>absence of an R wave in lead aVR</strong> reduces the likelihood of VT, pointing instead toward SVT with aberrant conduction.</li>\n</ul>\n</li>\n<li><strong>Clinical Implications</strong>:\n<ul>\n<li>Since Mr. Winters has structural heart disease, VT remains a strong consideration; however, the <strong>lack of specific ECG findings for VT</strong> (such as a monophasic R wave in aVR) leans towards SVT with aberrancy.</li>\n</ul>\n</li>\n</ol>\n<img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3d535v34tlady.cloudfront.net/V3/NEETPGMCQ/20250108cc2edef9-1631-4c18-8d62-f570be5ed331.jpg\">\n<ol>\n<li><strong>Option A: Findings consistent with atrioventricular dissociation</strong>:\n<ul>\n<li>AV dissociation (independent atrial and ventricular rhythms) is a reliable indicator of VT rather than SVT, as it suggests that the ventricles are generating their own rhythm without atrial influence.</li>\n</ul>\n</li>\n<li><strong>Option C: Presence of a monomorphic R wave in leads V1-V6</strong>:\n<ul>\n<li>Concordance of monomorphic R waves or S waves across the precordial leads (V1-V6) is highly specific for VT.</li>\n</ul>\n</li>\n<li><strong>Option D: The presence of structural heart disease</strong>:\n<ul>\n<li>Structural heart disease, such as a history of myocardial infarction, increases the likelihood of VT as the cause of a wide complex tachycardia due to the presence of scar tissue, which predisposes to ventricular arrhythmias.</li>\n</ul>\n</li>\n</ol>\n<p>Key Takeaways:</p>\n<ul>\n<li><strong>No R wave in lead aVR</strong> is more indicative of <strong>SVT with aberrancy</strong>, while an R or RS complex in aVR and monomorphic R waves or S waves across precordial leads suggest <strong>VT</strong>.</li>\n<li><strong>VT</strong> should be strongly suspected in patients with <strong>structural heart disease</strong> and wide complex tachycardia, but ECG clues help differentiate it from SVT with aberrancy.</li>\n</ul>",
      "correct_choice_id": 142,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    }
  ]
}